J H Newcorn

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi request reprint Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration
    Jeffrey H Newcorn
    Icahn School of Medicine at Mount Sinai
    J Am Acad Child Adolesc Psychiatry 52:921-30. 2013
  2. ncbi request reprint Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
    J Am Acad Child Adolesc Psychiatry 44:240-8. 2005
  3. doi request reprint Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai Medical Center, Box 1230, One Gustave L Levy Place, New York, NY 10029, USA
    Am J Psychiatry 165:721-30. 2008
  4. ncbi request reprint Symptom profiles in children with ADHD: effects of comorbidity and gender
    J H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, USA
    J Am Acad Child Adolesc Psychiatry 40:137-46. 2001
  5. doi request reprint Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Am Acad Child Adolesc Psychiatry 48:511-8. 2009
  6. doi request reprint Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder
    Jeffrey H Newcorn
    Mount Sinai School of Medicine, New York, NY 10029, USA
    J Am Acad Child Adolesc Psychiatry 48:1165-72. 2009
  7. ncbi request reprint Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder
    Jeffrey H Newcorn
    Mount Sinai Medical Center, Department of Psychiatry, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
    Pediatrics 118:e1701-6. 2006
  8. doi request reprint Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study
    Jeffrey H Newcorn
    Mount Sinai School of Medicine, New York, New York 10029, USA
    J Child Adolesc Psychopharmacol 20:187-96. 2010
  9. ncbi request reprint Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)
    J S March
    Department of Psychiatry, DUMC, Durham, NC 27710, USA
    J Abnorm Child Psychol 28:527-41. 2000
  10. ncbi request reprint ADHD comorbidity findings from the MTA study: comparing comorbid subgroups
    P S Jensen
    Center for the Advancement of Children s Mental Health, Columbia University NYSPI, 1051 Riverside Drive, Unit 78, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 40:147-58. 2001

Collaborators

Detail Information

Publications84

  1. ncbi request reprint Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration
    Jeffrey H Newcorn
    Icahn School of Medicine at Mount Sinai
    J Am Acad Child Adolesc Psychiatry 52:921-30. 2013
    ..To examine the efficacy and tolerability of guanfacine extended release (GXR) administered in the morning or evening in children with attention-deficit/hyperactivity disorder (ADHD)...
  2. ncbi request reprint Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
    J Am Acad Child Adolesc Psychiatry 44:240-8. 2005
    ..To examine (1) moderating effects of oppositional defiant disorder (ODD) on attention-deficit/hyperactivity disorder (ADHD) treatment response and (2) responses of ODD symptoms to atomoxetine...
  3. doi request reprint Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai Medical Center, Box 1230, One Gustave L Levy Place, New York, NY 10029, USA
    Am J Psychiatry 165:721-30. 2008
    ....
  4. ncbi request reprint Symptom profiles in children with ADHD: effects of comorbidity and gender
    J H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, USA
    J Am Acad Child Adolesc Psychiatry 40:137-46. 2001
    ....
  5. doi request reprint Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Am Acad Child Adolesc Psychiatry 48:511-8. 2009
    ..We conducted a retrospective analysis of randomized controlled trials (RCTs) to identify potential baseline (moderator) and on-treatment (mediator) predictors of responses...
  6. doi request reprint Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder
    Jeffrey H Newcorn
    Mount Sinai School of Medicine, New York, NY 10029, USA
    J Am Acad Child Adolesc Psychiatry 48:1165-72. 2009
    ....
  7. ncbi request reprint Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder
    Jeffrey H Newcorn
    Mount Sinai Medical Center, Department of Psychiatry, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
    Pediatrics 118:e1701-6. 2006
    ..However, lower doses could be effective during maintenance treatment, which would reduce drug exposure and potential problems related to tolerability during chronic treatment...
  8. doi request reprint Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study
    Jeffrey H Newcorn
    Mount Sinai School of Medicine, New York, New York 10029, USA
    J Child Adolesc Psychopharmacol 20:187-96. 2010
    ..Patient factors such as age, height, weight, and baseline symptom severity were evaluated as predictors of selected dose, as was the degree of incremental response with each successive dose escalation...
  9. ncbi request reprint Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)
    J S March
    Department of Psychiatry, DUMC, Durham, NC 27710, USA
    J Abnorm Child Psychol 28:527-41. 2000
    ..When treating ADHD, it is important to search for comorbid anxiety and negative affectivity and to adjust treatment strategies accordingly...
  10. ncbi request reprint ADHD comorbidity findings from the MTA study: comparing comorbid subgroups
    P S Jensen
    Center for the Advancement of Children s Mental Health, Columbia University NYSPI, 1051 Riverside Drive, Unit 78, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 40:147-58. 2001
    ..Determination of the clinical significance of potential ADHD + internalizing disorder or ADHD + ODD/CD syndromes could yield better diagnostic decision-making, treatment planning, and treatment outcomes...
  11. ncbi request reprint Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial
    L L Greenhill
    Clinical Psychiatry, Department of Psychiatry, Columbia University, New York, USA
    J Am Acad Child Adolesc Psychiatry 40:180-7. 2001
    ....
  12. ncbi request reprint Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers
    P S Jensen
    Center for the Advancement of Children s Mental Health, Department of Child Psychiatry, NYSPI Columbia University, New York, New York 10032, USA
    J Dev Behav Pediatr 22:60-73. 2001
    ..Parental attitudes and disciplinary practices appeared to mediate improved response to the Beh and Comb interventions...
  13. ncbi request reprint A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder
    Mark A Stein
    Department of Psychiatry, University of Chicago, Chicago, Illinois 60637, USA
    Pediatrics 112:e404. 2003
    ..This study was conducted to examine dosage effects on ADHD symptoms and stimulant side effects and to explore potential moderating effects of ADHD subtype...
  14. ncbi request reprint The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities
    Jeffrey H Newcorn
    Division of Child and Adolescent Psychiatry, Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 12:1-14; quiz 15-6. 2007
    ..Finally, Jeffrey H. Newcorn, MD, provides a discussion on the pharmacologic options available for adults with ADHD, considering dosages specific to adults and common comorbidities...
  15. ncbi request reprint Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Department of Child Psychiatry, New York State Psychiatric Institute, Columbia University, 1051 Riverside Dr, Suite 78, New York, NY 10032, USA
    Am J Psychiatry 162:1628-36. 2005
    ..To the authors' knowledge, this is the first study on the cost-effectiveness of the major forms of ADHD treatments used in NIMH's Multimodal Treatment Study of Children With ADHD (MTA Study)...
  16. ncbi request reprint Lack of seasonal rhythms in central serotonergic function in boys with ADHD
    Kurt P Schulz
    Neuropsychology Subprogram of the PhD Program in Psychology, Graduate Center of the City University of New York, 365 Fifth Avenue, New York, NY 1016, USA
    Psychoneuroendocrinology 27:463-73. 2002
    ..These results indicate that seasonality-related variance is not a threat to the validity of the neurochemical procedure and does not account for the inconsistencies in the studies of central 5-HT and aggression in children with ADHD...
  17. ncbi request reprint Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD
    L Eugene Arnold
    Department of Psychiatry, Ohio State University, USA
    J Consult Clin Psychol 71:713-27. 2003
    ..Treatment for lower socioeconomic status minority children, especially if comorbid, should combine medication and behavioral treatment...
  18. doi request reprint Guanfacine potentiates the activation of prefrontal cortex evoked by warning signals
    Suzanne M Clerkin
    Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
    Biol Psychiatry 66:307-12. 2009
    ..We tested the role that postsynaptic alpha(2A) adrenoceptors play in the activation of DLPFC evoked by warning cues using a placebo-controlled challenge with the alpha(2A) agonist guanfacine...
  19. pmc Perceptual and motor inhibition in adolescents/young adults with childhood-diagnosed ADHD
    Anne Claude V Bédard
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    Neuropsychology 24:424-34. 2010
    ..This study examined perceptual and motor inhibition in a longitudinal sample of adolescents/young adults who were diagnosed with ADHD in childhood, and as a function of the relative persistence of ADHD...
  20. ncbi request reprint Differential prefrontal cortex activation during inhibitory control in adolescents with and without childhood attention-deficit/hyperactivity disorder
    Kurt P Schulz
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Neuropsychology 19:390-402. 2005
    ..The magnitude of the prefrontal and basal ganglia activation was positively correlated with severity of ADHD. Response competition alone did not yield group differences in activation...
  21. ncbi request reprint Additive interaction of child abuse and perinatal risk as signs of resiliency in adulthood
    Yoko Nomura
    Child and Family Resilience Program, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York City, NY 10029, USA
    Ann N Y Acad Sci 1094:330-4. 2006
    ..An examination of the biological base of resilience could be added in a multidimensional/multifactorial model to help researchers identify ways to promote resiliency even before birth...
  22. ncbi request reprint Parents and clinicians underestimate distress and depression in children who had a transplant
    Eyal Shemesh
    Department of Psychiatry, Mount Sinai Medical Center, New York, NY 10029, USA
    Pediatr Transplant 9:673-9. 2005
    ..The child's report of his or her emotional symptoms should be directly sought post-transplant...
  23. ncbi request reprint Assessment of depression in medically ill children presenting to pediatric specialty clinics
    Eyal Shemesh
    Department of Psychiatry, Division of Child and Adolescent Psychiatry, NY 10029, USA
    J Am Acad Child Adolesc Psychiatry 44:1249-57. 2005
    ..This approach has not been validated. We evaluated the diagnostic accuracy of the Children's Depression Inventory (CDI) in medically ill children who were referred for evaluation by their pediatricians...
  24. ncbi request reprint The impact, identification, and management of attention-deficit/hyperactivity disorder in adults. Introduction
    Lenard A Adler
    New York University Medical Center, New York, NY, USA
    CNS Spectr 12:1-2. 2007
  25. pmc Relationship between whole blood serotonin and repetitive behaviors in autism
    Alexander Kolevzon
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Psychiatry Res 175:274-6. 2010
    ..No significant associations were found between serotonin level and the primary behavioral outcome measures. However, a significant inverse relationship between serotonin level and self-injury was demonstrated...
  26. ncbi request reprint Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disorders
    Jeffrey H Newcorn
    Mount Sinai School of Medicine, New York, USA
    Pediatr Ann 36:564-74. 2007
  27. pmc Low birth weight and risk of affective disorders and selected medical illness in offspring at high and low risk for depression
    Yoko Nomura
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Compr Psychiatry 48:470-8. 2007
    ..05), suggesting that parental depression may augment the impact of LBW on offspring depression:..
  28. ncbi request reprint Neurorobiology and evidence-based biological treatments for substance abuse disorders
    Iliyan S Ivanov
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    CNS Spectr 11:864-77. 2006
    ..This article will also review the pharmacologic agents used in the treatment of substance abuse disorders and presents evidence-based data for their safety, efficacy, and feasibility of use in different patient populations...
  29. ncbi request reprint Assessment of posttraumatic stress symptoms in children who are medically ill and children presenting to a child trauma program
    Eyal Shemesh
    Department of Psychiatry, Box 1230, Mount Sinai Medical Center, 1 Gustave L Levy Place, New York, NY 10029, USA
    Ann N Y Acad Sci 1071:472-7. 2006
    ..In conclusion, the U-PTSD-I performs better among general trauma versus medically ill patients. Intrusion symptoms should be focused on when assessing PTSD in medically ill children...
  30. ncbi request reprint The interaction of psychosocial adversity and biological risk in childhood aggression
    David J Marks
    Division of Child and Adolescent Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Psychiatry Res 151:221-30. 2007
    ..In contrast, no such interaction was observed for teacher-rated aggression. Findings suggest that individuals at biological risk for aggression may be particularly vulnerable to the impact of psychosocial adversity...
  31. ncbi request reprint Comparison of parent and child reports of emotional trauma symptoms in pediatric outpatient settings
    Eyal Shemesh
    Department of Psychiatry, Mount Sinai Medical Center, 1 Gustave L Levy Pl, Box 1230, New York, NY 10029, USA
    Pediatrics 115:e582-9. 2005
    ..This study evaluated discrepancies in parental versus child reports of the child's emotional trauma symptoms in pediatric medical care settings...
  32. ncbi request reprint Assessment and treatment of depression in medically ill children
    Eyal Shemesh
    Division of Child and Adolescent Psychiatry, Department of Psychiatry, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Curr Psychiatry Rep 4:88-92. 2002
    ..Because treatment of depression in medically ill children may well lead to improvement in medical and psychiatric outcome, there is pressing need for the careful study of potential treatment options in this specific group of patients...
  33. pmc Event-related FMRI of inhibitory control in the predominantly inattentive and combined subtypes of ADHD
    Mary V Solanto
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Neuroimaging 19:205-12. 2009
    ....
  34. ncbi request reprint Pediatric emergency department assessment of psychological trauma and posttraumatic stress
    Eyal Shemesh
    Department of Psychiatry, Mount Sinai Medical Center, 1 Gustave L Levy Place, New York, NY 10029, USA
    Psychiatr Serv 54:1277-81. 2003
    ....
  35. pmc Neurocognitive functioning in AD/HD, predominantly inattentive and combined subtypes
    Mary V Solanto
    Department of Psychiatry, The Mount Sinai School of Medicine, Box 1230, Gustave Levy Place, New York, NY 10029 6574, USA
    J Abnorm Child Psychol 35:729-44. 2007
    ..Neuropsychological methods have yet to identify critical neuropsychological [corrected] substrates of these differences...
  36. pmc Dissociable neural effects of stimulus valence and preceding context during the inhibition of responses to emotional faces
    Kurt P Schulz
    Department of Psychiatry, The Mount Sinai School of Medicine, New York 10029, USA
    Hum Brain Mapp 30:2821-33. 2009
    ....
  37. pmc The risk for impaired learning-related abilities in childhood and educational attainment among adults born near-term
    Yoko Nomura
    Department of Psychiatry, Queens College, New York, NY, USA
    J Pediatr Psychol 34:406-18. 2009
    ....
  38. ncbi request reprint Co-morbidity in adults with ADHD
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 13:12-5. 2008
  39. ncbi request reprint Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: an event-related FMRI study
    Kurt P Schulz
    Department of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
    Am J Psychiatry 161:1650-7. 2004
    ..The present study used behavioral and functional neuroimaging techniques to examine inhibitory control processes in adolescents who had been diagnosed with ADHD during childhood...
  40. pmc Roles of perinatal problems on adolescent antisocial behaviors among children born after 33 completed weeks: a prospective investigation
    Yoko Nomura
    Mount Sinai School of Medicine, Department of Psychiatry, New York, NY 10029USA
    J Child Psychol Psychiatry 49:1108-17. 2008
    ..There is even more uncertainty about whether the pathway to antisocial behavior differs by gender...
  41. doi request reprint Inhibitory control deficits in childhood and risk for substance use disorders: a review
    Iliyan Ivanov
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
    Am J Drug Alcohol Abuse 34:239-58. 2008
    ..Hypotheses developed using this approach can be more definitively evaluated in longitudinal studies with these same populations, extending through the period of maximal risk for SUD in adolescence and early adulthood...
  42. ncbi request reprint Brain activation gradients in ventrolateral prefrontal cortex related to persistence of ADHD in adolescent boys
    Kurt P Schulz
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Am Acad Child Adolesc Psychiatry 44:47-54. 2005
    ..To explore the possible role that functional abnormalities of the prefrontal cortex and basal ganglia play in the persistence of attention-deficit/hyperactivity disorder (ADHD) in adolescents aged 15 to 19 years...
  43. ncbi request reprint Relationship between central serotonergic function and aggression in prepubertal boys: effect of age and attention-deficit/hyperactivity disorder
    K P Schulz
    Neuropsychology Subprogram of the Ph.D. Program in Psychology, The Graduate Center of CUNY, New York, NY 10016, USA
    Psychiatry Res 101:1-10. 2001
    ..Moreover, these data do not confirm the hypothesis that age or the presence of ADHD influence the relationship between 5-HT and childhood aggression...
  44. pmc Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome
    Robyn L Powers
    The Graduate Center, City University of New York, New York, NY, USA
    J Child Adolesc Psychopharmacol 18:449-59. 2008
    ..Psychostimulant treatment for children with ADHD may benefit long-term adolescent academic performance, although the extent of improvement is likely to vary as a function of multiple factors...
  45. ncbi request reprint Pharmacotherapy of aggression in a 9-year-old with ADHD
    Robert L Findling
    Department of Psychiatry, University Hospital of Cleveland Case Western Reserve University, Cleveland, Ohio 44106, USA
    J Am Acad Child Adolesc Psychiatry 46:653-8. 2007
  46. ncbi request reprint Age-related considerations in the treatment of ADHD
    Jeffrey H Newcorn
    Division of Child and Adolescent Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    CNS Spectr 12:10-3. 2007
  47. ncbi request reprint Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder
    Timothy E Wilens
    Massachusetts General Hospital, Department of Psychiatry, Boston, Massachusetts, USA
    J Pediatr 149:112-9. 2006
    ..To determine the efficacy and safety of atomoxetine in adolescent subjects treated for attention-deficit/hyperactivity disorder (ADHD) for up to 2 years...
  48. ncbi request reprint Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms
    Christopher J Kratochvil
    Department of Psychiatry, Nebraska Medical Center, Omaha 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 44:915-24. 2005
    ..The authors assessed the safety and effectiveness of atomoxetine monotherapy compared with combined atomoxetine/fluoxetine therapy in a population of children and adolescents with ADHD and concurrent symptoms of depression or anxiety...
  49. ncbi request reprint Comorbidity in adults with attention-deficit/hyperactivity disorder
    D J Marks
    Neuropsychology Doctoral Program, Department of Psychology, Graduate School and University Center, City University of New York, New York, New York 10016, USA
    Ann N Y Acad Sci 931:216-38. 2001
    ..However, the reported prevalence of comorbid conditions among adults with ADHD varies considerably depending upon whether the research used a prospective or retrospective design...
  50. ncbi request reprint Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects
    Brooke S G Molina
    Department of Psychiatry, University of Pittsburgh School of Medicine, 3811 O Hara Street, Pittsburgh, PA 15213, USA
    J Am Acad Child Adolesc Psychiatry 46:1028-40. 2007
    ....
  51. ncbi request reprint Managing ADHD and comorbidities in adults
    Jeffrey H Newcorn
    The Division of Child and Adolescent Psychiatry, Department of Psychiatry, Mt Sinai School of Medicine, New York, NY, USA
    J Clin Psychiatry 70:e40. 2009
    ..Comorbidity may alter the patient's response to ADHD treatment and often requires treatment that is independent of and distinct from the treatment for ADHD...
  52. ncbi request reprint 3-year follow-up of the NIMH MTA study
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Unit 78, Columbia University NYSPI, 1051 Riverside Drive, New York, NY 10027, USA
    J Am Acad Child Adolesc Psychiatry 46:989-1002. 2007
    ..This report examines 36-month outcomes, 2 years after treatment by the study ended...
  53. ncbi request reprint Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder
    Karen C Wells
    Department of Psychiatry, Duke University Medical Center, Durham, NC, USA
    J Consult Clin Psychol 74:649-57. 2006
    ..The authors discuss the importance of changes in parenting behavior for families of children with ADHD and the need for reliable and objective measures in evaluating treatment outcome...
  54. ncbi request reprint Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, Box 1230, 1 Gustave L Levy Place, New York, NY 10029, USA
    Curr Psychiatry Rep 6:85-7. 2004
  55. ncbi request reprint The effect of childhood conduct disorder and cognitive functioning on adolescent substance use
    Seth C Harty
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 9:661-6. 2004
    ..To assess the impact of childhood conduct disorder (CD) and intelligence quotient (IQ) on later substance use in adolescence...
  56. ncbi request reprint Adolescent outcome of ADHD: impact of childhood conduct and anxiety disorders
    Jeffrey H Newcorn
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 9:668-78. 2004
    ..the negative behavioral outcome of youth with ADHD?; and (4) Is there an interaction between comorbid CD and anxiety disorders, when they occur simultaneously, that predicts a different outcome than either comorbid condition alone?..
  57. ncbi request reprint Growth hormone response to guanfacine in boys with attention deficit hyperactivity disorder: a preliminary study
    Jeffrey M Halperin
    Department of Psychology, Queens College of the City University of New York, New York, New York 11367, USA
    J Child Adolesc Psychopharmacol 13:283-94. 2003
    ....
  58. ncbi request reprint Childhood abuse, nonadherence, and medical outcome in pediatric liver transplant recipients
    Eyal Shemesh
    Department of Psychiatry, Recanati Miller Transplant Institute at Mount Sinai Medical Center, New York, NY, USA
    J Am Acad Child Adolesc Psychiatry 46:1280-9. 2007
    ..The study assessed the relationship between a history of child abuse, nonadherence to medications, and medical outcome in children who had a liver transplant...
  59. ncbi request reprint Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial
    Christopher J Kratochvil
    University of Nebraska Medical Center, USA
    J Am Acad Child Adolesc Psychiatry 41:776-84. 2002
    ..Atomoxetine was originally called tomoxetine. The name was recently changed in order to avoid any potential confusion with tamoxifen that might lead to errors in dispensing drug.)..
  60. ncbi request reprint Which treatment for whom for ADHD? Moderators of treatment response in the MTA
    Elizabeth B Owens
    Institute of Human Development, University of California, Berkeley 94720 1690, USA
    J Consult Clin Psychol 71:540-52. 2003
    ..No predictors or moderators emerged for behavioral and community comparison treatments. The authors discuss conceptual and clinical implications of research on treatment moderators...
  61. ncbi request reprint Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment
    Thomas J Spencer
    Massachusetts General Hospital Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
    J Child Adolesc Psychopharmacol 17:689-700. 2007
    ..To examine the effects on growth of long-term pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD), we present findings from an ongoing 5-year study of the efficacy and safety of treatment with atomoxetine...
  62. ncbi request reprint The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder
    Louis S Matza
    MEDTAP International, Inc, Bethesda, Maryland, USA
    J Dev Behav Pediatr 25:166-74. 2004
    ..The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment...
  63. ncbi request reprint Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures
    L Eugene Arnold
    The Ohio State University, Columbus, Ohio, USA
    J Abnorm Child Psychol 32:39-51. 2004
    ....
  64. ncbi request reprint Amphetamine salt compound treatment for adults with attention deficit hyperactivity disorder
    Jeffrey H Newcorn
    Curr Psychiatry Rep 4:85-6. 2002
  65. ncbi request reprint Familial correlates of central serotonin function in children with disruptive behavior disorders
    Jeffrey M Halperin
    Department of Psychology, Queens College of CUNY, 65 30 Kissena Boulevard, Flushing, NY 11367, USA
    Psychiatry Res 119:205-16. 2003
    ..These data suggest that there are both familial and non-familial forms of aggression in children, and that only the familial type is associated with reduced 5-HT function...
  66. ncbi request reprint Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution
    Howard Abikoff
    Child and Adolescent Psychiatry, NYU Child Study Center, NYU School of Medicine, NY 10016, USA
    J Am Acad Child Adolesc Psychiatry 41:498-504. 2002
    ..Although the manual-based guidelines are especially applicable to multisite RCTs, many of the procedures in the ASAP Manual can apply to any treatment study in children...
  67. ncbi request reprint Do children and adolescents with ADHD respond differently to atomoxetine?
    Timothy E Wilens
    Massachusetts General Hospital, Boston, MA 02114 3117, USA
    J Am Acad Child Adolesc Psychiatry 45:149-57. 2006
    ..Here the authors report data contrasting the efficacy and tolerability of atomoxetine between children and adolescents with attention-deficit/hyperactivity disorder (ADHD)...
  68. ncbi request reprint Serotonergic function in children with attention-deficit hyperactivity disorder: relationship to later antisocial personality disorder
    Janine D Flory
    Department of Psychology, Queens College, City University of New York, 65 30 Kissena Boulevard, SB 318 Flushing, NY 11367, USA
    Br J Psychiatry 190:410-4. 2007
    ..Impulsive aggression in adulthood is associated with disturbances in serotonergic function. In contrast, research examining this association in childhood has yielded inconsistent results...
  69. ncbi request reprint Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine
    Laurence L Greenhill
    The New York State Psychiatric Institute Columbia University, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 46:566-72. 2007
    ..To compare the effects of two different methods for initiating atomoxetine in terms of the incidence of early adverse events...
  70. ncbi request reprint Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data
    Joseph Biederman
    Pediatric Psychopharmacology Unit, Massachusetts General Hospital Harvard Medical School, Yawkey Center for Outpatient Care 6A, Boston, MA 02114, USA
    Psychopharmacology (Berl) 190:31-41. 2007
    ....
  71. ncbi request reprint Personality characteristics associated with persistent ADHD in late adolescence
    Carlin J Miller
    Department of Psychology, University of Windsor, 401 Sunset Avenue, Windsor, Ontario N9B 3P4, Canada
    J Abnorm Child Psychol 36:165-73. 2008
    ..These results suggest that ADHD, and the degree to which symptoms persist into adolescence, may be closely linked to personality structure...
  72. ncbi request reprint High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, NE 68198, USA
    J Am Acad Child Adolesc Psychiatry 46:1128-37. 2007
    ..To assess the utility and tolerability of higher than standard atomoxetine doses to treat attention-deficit/hyperactivity disorder (ADHD)...
  73. ncbi request reprint Elevated childhood serotonergic function protects against adolescent aggression in disruptive boys
    Jeffrey M Halperin
    Psychology Department, Queens College, 65 30 Kissena Boulevard, Flushing, NY 11367, USA
    J Am Acad Child Adolesc Psychiatry 45:833-40. 2006
    ..This longitudinal study examined whether responsiveness of the neurotransmitter serotonin (5-HT) in childhood predicts adolescent aggression...
  74. ncbi request reprint Assessing medication effects in the MTA study using neuropsychological outcomes
    Jeffery N Epstein
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Child Psychol Psychiatry 47:446-56. 2006
    ....
  75. ncbi request reprint Family and cognitive factors: modeling risk for aggression in children with ADHD
    Carlin J Miller
    Department of Psychology, Queens College, City University of New York, Flushing 11367, USA
    J Am Acad Child Adolesc Psychiatry 45:355-63. 2006
    ..To explore the relationships of family and cognitive factors to aggression as reported by parents and teachers...
  76. ncbi request reprint Reliability, validity, and preliminary normative data for the Children's Aggression Scale-Teacher Version
    Jeffrey M Halperin
    Department of Psychology, Queens College of the City University of New York, USA
    J Am Acad Child Adolesc Psychiatry 42:965-71. 2003
    ..To provide preliminary psychometric data on the Children's Aggression Scale-Teacher Version (CAS-T), which was designed to assess severity and frequency of aggressive, as distinct from nonaggressive, disruptive behaviors...
  77. ncbi request reprint Socioeconomic status as a moderator of ADHD treatment outcomes
    Ricardo Rieppi
    Department of Psychology, St Johns University, Jamaica, NY 11439, USA
    J Am Acad Child Adolesc Psychiatry 41:269-77. 2002
    ....
  78. ncbi request reprint Development, reliability, and validity of the children's aggression scale-parent version
    Jeffrey M Halperin
    Department of Psychology, Queens College of the City University of New York, and Mount Sinai School of Medicine, Flushing 11367, USA
    J Am Acad Child Adolesc Psychiatry 41:245-52. 2002
    ..To provide preliminary psychometric data on the Children's Aggression Scale-Parent Version (CAS-P), which assesses severity, frequency, pervasiveness, and diversity of aggressive, as distinct from nonaggressive, disruptive behaviors...
  79. doi request reprint Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details
    James Swanson
    UCI Child Development Center, University of California, Irvine, Irvine, CA 92612, USA
    J Atten Disord 12:15-43. 2008
    ..To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles...
  80. doi request reprint Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary
    James Swanson
    UCI Child Development Center, University of California, Irvine, Irvine, CA 92612, USA
    J Atten Disord 12:4-14. 2008
    ..To review the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published over the past decade as three sets of articles...
  81. ncbi request reprint Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder
    Betsy Hoza
    Department of Psychological Sciences, Purdue University, West Lafayette, IN 47907 2081, USA
    J Clin Child Adolesc Psychol 34:74-86. 2005
    ..Results indicated that children from all groups remained significantly impaired in their peer relationships...
  82. ncbi request reprint Effects of stimulant medication on growth rates across 3 years in the MTA follow-up
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1015-27. 2007
    ..To evaluate the hypothesis of stimulant medication effect on physical growth in the follow-up phase of the Multimodal Treatment Study of Children With ADHD...
  83. ncbi request reprint Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1003-14. 2007
    ....
  84. ncbi request reprint Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder
    Thomas J Spencer
    Massachusetts General Hospital, Boston, MA 02114, USA
    Pediatrics 116:e74-80. 2005
    ..This meta-analysis examined the effect on growth of atomoxetine, now approved in the United States for the treatment of attention-deficit/hyperactivity disorder...

Research Grants7

  1. Dopamine and ADHD: A Research Infrastructure Network
    Jeffrey Newcorn; Fiscal Year: 2004
    ..In addition, the post-doctoral students will be able to spend time in multiple laboratories, which will facilitate the transfer of key theoretical and technical expertise across sites. ..
  2. Predicting Response to Atomoxetine and Methlyphenidate
    Jeffrey Newcorn; Fiscal Year: 2005
    ..abstract_text> ..
  3. Predicting Response to Atomoxetine and Methlyphenidate
    Jeffrey Newcorn; Fiscal Year: 2006
    ..abstract_text> ..
  4. Methylphenidate and Atomoxetine in ADHD: fMRI Measures of Mechanisms and Response
    Jeffrey Newcorn; Fiscal Year: 2006
    ..We will also collect pilot data on neurobiological predictors of differential response. ..
  5. Predicting Response to Atomoxetine and Methlyphenidate
    Jeffrey Newcorn; Fiscal Year: 2007
    ..abstract_text> ..
  6. Predicting Response to Atomoxetine and Methlyphenidate
    Jeffrey Newcorn; Fiscal Year: 2009
    ..abstract_text> ..